XML 39 R22.htm IDEA: XBRL DOCUMENT v3.19.2
Long Term Debt and Other Borrowings
12 Months Ended
Jun. 30, 2019
Debt Disclosure [Abstract]  
Long Term Debt and Other Borrowings Long Term Debt and Other Borrowings
As of June 30, 2019, and June 24, 2018, the Company’s outstanding debt consisted of the following:
 
June 30, 2019
 
June 24, 2018
 
 
Amount
(in thousands)
 
Effective Interest Rate
 
Amount
(in thousands)
 
Effective Interest Rate
 
Fixed-rate 2.75% Senior Notes Due March 15, 2020 (“2020 Notes”)
500,000

 
2.88
%
 
500,000

 
2.88
%
 
Fixed-rate 2.80% Senior Notes Due June 15, 2021 (“2021 Notes”)
800,000

 
2.95
%
 
800,000

 
2.95
%
 
Fixed-rate 3.80% Senior Notes Due March 15, 2025 (“2025 Notes”)
500,000

 
3.87
%
 
500,000

 
3.87
%
 
Fixed-rate 3.75% Senior Notes Due March 15, 2026 ("2026 Notes")
750,000

 
3.86
%
 

 

 
Fixed-rate 4.00% Senior Notes Due March 15, 2029 ("2029 Notes")
1,000,000

 
4.09
%
 

 

 
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (“2041 Notes”)
212,349

(1)
4.28
%
 
326,953

(1)
4.28
%
 
Fixed-rate 4.875% Senior Notes Due March 15, 2049 ("2049 Notes")
750,000

 
4.93
%
 

 

 
Commercial paper

 

 
360,000

 
2.33
%
(2)
Total debt outstanding, at par
4,512,349

 
 
 
2,486,953

 
 
 
Unamortized discount
(73,191
)
 
 
 
(85,196
)
 
 
 
Fair value adjustment - interest rate contracts
(3,612
)
 
 
 
(31,189
)
 
 
 
Unamortized bond issuance costs
(5,535
)
 
 
 
(1,820
)
 
 
 
Total debt outstanding, at carrying value
$
4,430,011

 
 
 
$
2,368,748

 

 
Reported as:
 
 
 
 
 
 
 
 
Current portion of long-term debt and commercial paper
$
662,308

 
 
 
$
608,532

 
 
 
Long-term debt
3,767,703

 
 
 
1,760,216

 
 
 
Total debt outstanding, at carrying value
$
4,430,011

 
 
 
$
2,368,748

 
 
 
(1)
As of the report date, these notes were convertible at the option of the bondholder. This is a result of the following condition being met: the market value of the Company’s Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the 2041 Notes were classified in current liabilities and a portion of the equity component associated with the convertible notes, representing the unamortized discount, was classified in temporary equity on the Company’s Consolidated Balance Sheets. Upon closure of the conversion period, the notes not converted will be reclassified back into noncurrent liabilities and the temporary equity will be reclassified into permanent equity.
(2)
Represents the weighted-average effective interest rate for all outstanding balances as of the report date.
The Company’s contractual cash obligations relating to its outstanding debt as of June 30, 2019, were as follows: 
Payments Due by Fiscal Year:

 
(in thousands)
2020 (1)
$
712,349

2021
800,000

2022

2023

2024

Thereafter
3,000,000

Total
$
4,512,349

(1)
As noted above, the conversion period for the 2041 Notes is open as of June 30, 2019. As there is the potential for conversion at the option of the holder, the principal balance of the 2041 Notes has been included in the one-year payment period.
Convertible Senior Notes
In June 2012, with the acquisition of Novellus, the Company assumed $700 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 15, 2041 (the “2041 Notes”). The Company pays cash interest at an annual rate of 2.625%, on a semi-annual basis on May 15 and November 15 of each year. The 2041 Notes also have a contingent interest payment provision that may require the Company to pay additional interest, up to 0.60% per year, based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes.
The Company separately accounts for the liability and equity components of the 2041 Notes. The initial debt components of the 2041 Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature, which equals the effective interest rate on the liability component disclosed in the table below, respectively. The equity component was
initially valued equal to the principle value of the notes, less the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without a conversion feature, which equated to the initial debt discount.
The 2041 Notes may be redeemed on or after May 21, 2021 at a price equal to outstanding principal plus accrued and unpaid interest if the last reported sales price of common shares has been equal to or more than 150% of the then applicable conversion price for at least 20 trading days during the 30 consecutive trading days prior to the redemption notice date.
Under certain circumstances, the 2041 Notes may be converted into shares of the Company’s Common Stock. The number of shares each debenture is convertible into is based on conversion rates, disclosed in the table below. The principal value of the 2041 Note conversions in the fiscal year ended June 30, 2019, were $114.6 million. During the quarter ended June 30, 2019 and in the subsequent period through August 16, 2019, the Company received notice of conversion for an additional $27.9 million principal value of 2041 Notes, which will settle in the quarter ending September 29, 2019.
Selected additional information regarding the 2041 Notes outstanding as of June 30, 2019, and June 24, 2018, is as follows: 
 
2041 Notes
 
June 30,
2019
 
June 24,
2018
 
(in thousands, except years, percentages, conversion rate, and conversion price)
Carrying amount of permanent equity component, net of tax
$
160,604

 
$
159,120

Carrying amount of temporary equity component, net of tax
$
49,439

 
$
78,192

Remaining amortization period (years)
21.9

 
22.9

Fair Value of Notes (Level 2)
$
1,229,475

 
 
Conversion rate (shares of common stock per $1,000 principal amount of notes)
30.9197

 
 
Conversion price (per share of common stock)
$
32.34

 
 
If-converted value in excess of par value
$
1,020,965

 
 
Estimated share dilution using average quarterly stock price of $189.73 per share
5,447

 
 

Convertible Warrants
During the fiscal year 2019, the Company had warrants outstanding in connection with its 2018 convertible notes that matured in May 2018. The 7.6 million warrants were fully exercised during the fiscal year ended June 30, 2019, resulting in the issuance of approximately 4.1 million shares of the Company’s Common Stock.
Senior Notes
On March 4, 2019, the company completed a public offering of $750 million aggregate principal amount of the Company’s Senior Notes due March 15, 2026 (the “2026 Notes”), $1.0 billion aggregate principal amount of the Company’s Senior Notes due March 15, 2029 (the “2029 Notes”), and $750 million aggregate principal amount of the Company’s Senior Notes due March 15, 2049 (the “2049 Notes”). The Company will pay interest at an annual rate of 3.75%, 4.00%, and 4.875%, on the 2026, 2029, and 2049 Notes, respectively, on a semi-annual basis on March 15 and September 15 of each year beginning September 15, 2019.
On March 12, 2015, the Company completed a public offering of $500 million aggregate principal amount of the Company’s Senior Notes due March 15, 2020 (the “2020 Notes”) and $500 million aggregate principal amount of the Company’s Senior Notes due March 15, 2025 (the “2025 Notes”). The Company pays interest at an annual rate of 2.75% and 3.80% on the 2020 Notes and 2025 Notes, respectively, on a semi-annual basis on March 15 and September 15 of each year. During the year ended June 26, 2016, the Company entered into a series of interest rate contracts hedging the fair value of a portion of the 2025 Notes par value, whereby the Company receives a fixed rate and pays a variable rate based on a certain benchmark interest rate. Refer to Note 9 - Financial Instruments for additional information regarding these interest rate contracts.
On June 7, 2016, the Company completed a public offering of $800 million aggregate principal amount of Senior Notes due June 2021 (the “2021 Notes”). The Company pays interest at an annual rate of 2.80% on the 2021 Notes on a semi-annual basis on June 15 and December 15 of each year.
The Company may redeem the 2020, 2021, 2025, 2026, 2029 and 2049 Notes (collectively the “Senior Notes”) at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect to the Senior Notes and accrued and unpaid interest before February 15, 2020, for
the 2020 Notes, before May 15, 2021 for the 2021 Notes, before December 15, 2024 for the 2025 Notes, before January 15, 2026 for the 2026 Notes, before December 15, 2028 for the 2029 Notes, and before September 15, 2048 for the 2049 Notes. The Company may redeem the Senior Notes at par, plus accrued and unpaid interest at any time on or after February 15, 2020, for the 2020 Notes, on or after May 15, 2021 for the 2021 Notes, on or after December 24, 2024, for the 2025 Notes, on or after January 15, 2026 for the 2026 Notes, on or after December 15, 2028 for the 2029 Notes, and on or after September 15, 2048 for the 2049 Notes. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the Senior Notes at a price equal to 101% of the principal amount of the respective note, plus accrued and unpaid interest.
Selected additional information regarding the Senior Notes outstanding as of June 30, 2019, is as follows: 
 
Remaining Amortization period
 
Fair Value of Notes (Level 2)
 
(years)
 
(in thousands)
2020 Notes
0.7
 
$
500,855

2021 Notes
2.0
 
$
806,232

2025 Notes
5.7
 
$
528,895

2026 Notes
6.7
 
$
786,915

2029 Notes
9.7
 
$
1,063,670

2049 Notes
29.7
 
$
828,188


Revolving Credit Facility
On March 12, 2014, the Company established an unsecured Credit Agreement. This agreement was amended on November 10, 2015 (the “Amended and Restated Credit Agreement”), October 13, 2017 (the “2nd Amendment”), and February 25, 2019 (the “3rd Amendment”). Under the Amended and Restated Credit Agreement (as amended by the 2nd and 3rd Amendment), the Company has a revolving credit facility of $1.25 billion with a syndicate of lenders with an expansion option that will allow the Company, subject to certain requirements, to request an increase in the facility of up to an additional $600.0 million, for a potential total commitment of $1.85 billion. The facility matures on October 13, 2022.
Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (1) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) one-month LIBOR plus 1.0%, plus a spread of 0.0% to 0.5%, or (2) LIBOR multiplied by the statutory rate, plus a spread of 0.9% to 1.5%, in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s credit rating. The Amended and Restated Credit Agreement contains affirmative covenants, negative covenants, financial covenants, and events of default. As of June 30, 2019, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.
Commercial Paper Program
On November 13, 2017, the Company established a commercial paper program under which the Company may issue unsecured commercial paper notes on a private placement basis up to a maximum aggregate principal amount of $1.25 billion. The net proceeds from the CP Program will be used for general corporate purposes, including repurchases of the Company’s Common Stock from time to time under the Company’s stock repurchase program. Amounts available under the CP Program may be re-borrowed. The CP Program is backstopped by the Company’s Revolving Credit Arrangement. As of June 30, 2019, the Company had no outstanding borrowings under the CP Program.
Interest Cost
The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Senior Notes, convertible notes, the term loan agreement, commercial paper, and the revolving credit facility during the fiscal years ended June 30, 2019June 24, 2018, and June 25, 2017. 
 
Year Ended
 
June 30,
2019
 
June 24,
2018
 
June 25,
2017
 
(in thousands)
Contractual interest coupon
$
100,712

 
$
77,091

 
$
95,195

Amortization of interest discount
3,937

 
12,225

 
22,873

Amortization of issuance costs
1,426

 
2,034

 
2,414

Effect of interest rate contracts, net
4,086

 
3

 
(4,756
)
Total interest cost recognized
$
110,161

 
$
91,353

 
$
115,726



The increase in interest expense during the 12 months ended June 30, 2019, is primarily the result of the issuance of $2.5 billion of Senior Notes in March 2019.